US Patent 7446112 Modulators of muscarinic receptors

Patent 7446112 was granted and assigned to Vertex Pharmaceuticals on November, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Vertex Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

74461120

Patent Inventor Names

Miguel Garcia-Guzman Blanco0

Philip Martin Londo0

Lewis R. Makings0

Peter D. J. Grootenhuis0

Date of Patent

November 4, 2008

Patent Application Number

110059440

Date Filed

December 7, 2004

Patent Citations Received

‌

US Patent 11912668 GCN2 and perk kinase inhibitors and methods of use thereof

Patent Primary Examiner

‌

Taofiq A. Solola

Patent abstract

The modulator compounds described herein modulate muscarinic receptors and are useful for treating muscarinic receptor mediated diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7446112 Modulators of muscarinic receptors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API